Clinical Presentation and Diagnosis of Intestinal Adenocarcinoma in Crohn's Disease: Analysis of Clinical Predictors and of the Life-Time Risk

Journal of Gastrointestinal Surgery

Volumn 14, Issue 11, 2010, Pages 1746-1751

  Ruffolo, Cesare ^a   Bassi, N ^a   Scarpa, Marco ^b   Polese, Lino ^c   D'Amico, Francesco E ^c   Boetto, Riccardo ^c   Pozza, Anna ^c   D'Incà, Renata ^c   Checchin, Davide ^c   Sturniolo, Giacomo Carlo ^c   Angriman, Imerio ^c  

^a Regional Hospital C Foncello   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adenocarcinoma; Crohn's disease; Endoscopic surveillance

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CROHN DISEASE; FEMALE; HUMAN; INTESTINE TUMOR; MALE; MIDDLE AGED; PATHOLOGY; RISK;

ADENOCARCINOMA; ADULT; AGED; CROHN DISEASE; FEMALE; HUMANS; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; RISK;

EID: 77958471976     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1265-0     Document Type: Article

References (21)

1. Friedman S. Cancer in Crohn's disease. Gastroenterol Clin North Am. 2006; 35: 621-639.
2. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359.
3. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population based study. Cancer 2001; 91: 854-862.
4. Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population- based cohort studies. Am J Gastroenterol 2005; 100: 2724-2729.
5. Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum. 2006; 49: 950-957.
6. Freeman HJ. Colorectal cancer complicating Crohn's disease. Can J Gastroenterol 2001; 15: 231-236.
7. Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J Gastroenterol. 2008; 14: 378-389.
8. Kersting S, Bruewer M, Laukoetter MG, Rijcken EM, Mennigen R, Buerger H, Senninger N, Krieglstein CF. Intestinal cancer in patients with Crohn's disease. Int J Colorectal Dis. 2007; 22: 411-417.
9. Rubio CA, Befrits R Colorectal cancer in Crohn's disease--review of a 56-year experience in Karolinska Institute University Hospital. J Environ Pathol Toxicol Oncol. 2008; 27: 257-266.
10. Rubio CA, Kapraali M, Befrits R. Further studies on the frequency of colorectal cancer in Crohn's colitis: an 11-year survey in the Northwest Stockholm County. Anticancer Res. 2009; 29: 4291-4295-.
11. Bernstein CN. How do we assess the value of surveillance techniques in ulcerative colitis? J Gastrointest Surg 1998; 2: 318-321.
12. Friedman S, Rubin PH, Bodian C, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol. 2008; 6: 993-998.
13. Strong SA, Koltun WA, Hyman NH, Buie WD; Standards Practice Task Force of The American Society of Colon and Rectal Surgeons Practice parameters for the surgical management of Crohn's disease. Dis Colon Rectum. 2007; 50: 1735-1746.
14. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994; 35: 950-954.
15. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981; 48: 2742-2745.
16. Gillen CD, Andrews HA, Prior P, Allan RN. Crohn's disease and colorectal cancer. Gut 1994; 35(5): 651-5.
17. van Staa TP, Card T, Logan RF, Leufkens HG. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 2005; 54: 1573-1578.
18. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol. 2005; 100: 1345-1353.
19. Freeman HJ. What is the cancer risk in Crohn's disease? Inflamm Bowel Dis 2008; 14 (S2): S63-64.
20. D'Incà R, Cardin R, Benazzato L, Angriman I, Martines D, Sturniolo GC. Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm Bowel Dis. 2004; 10: 23-27.
21. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Scand J Gastroenterol. 2009; 44: 46-55.